MedPath

comparing intraartcular ropivacaine with intraarticualr dexmedetomidine orcombination of both

Phase 4
Conditions
Health Condition 1: null- ASA I and II
Registration Number
CTRI/2017/06/008762
Lead Sponsor
Government Medical College Jammu
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
108
Inclusion Criteria

After the ethic committeeâ??s approval, informed written consents were obtained from 108 patients, ASA physical status Iâ??II, age between 18 and 65, scheduled to undergo elective arthroscopic knee surgery.

Exclusion Criteria

Exclusion criteria included Patient refusal, any known allergy or contraindication to ropivacaine, or dexmedetomidine, pregnancy, lactating mothers and children, hepatic, renal or cardiopulmonary abnormality, long-term analgesic therapy, spinal cord deformities, bleeding diathesis, local skin site infections , and morbid obesity (body mass index > 35)..

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath